NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1...

Submit YOUR Ideas for New NIH Study

allofuslogo The National Institutes of Health (NIH) is asking the research community for ideas for research questions that might be addressed through the All of Us research study. The All of Us study is a major NIH investment with the goal of enrolling over 1 million Americans in a longitudinal cohort study, thereby building “one of...

Special Diabetes Program In Jeopardy; Congress Needs to Hear from You

As Congress readies itself for the next federal budget deadline (February 8), funding for the Special Diabetes Program (SDP) remains uncertain. A top priority for the Endocrine Society is funding the SDP, which includes the Special Type 1 Program that funds NIH research and the Special Diabetes Program for Indians that provides diabetes education and...

Helmsley Charitable Trust Launches New Diabetes Research Grant

The Leona M. and Harry B. Helmsley Charitable Trust’s Type 1 Diabetes Program has launched a funding opportunity through its new Future Technologies Initiative. The goal of Future Technologies Initiative is to accelerate the development of novel, early-stage, disruptive technologies that have the potential to change the current state of type 1 diabetes management and...

Advocacy Roundtable: Taking Action for Endocrinology

1217_AdvocacyRoundtable When the Rally for Medical Research took place in Washington, D.C., in September, among the voices were several Endocrine Society members. We spoke to Lindsey Trevino, PhD, T. Rajendra Kumar, PhD, Heather Patisaul, PhD, and Benson Akingbemi, PhD, about why they feel so strongly about becoming “endocrine advocates.” In September, the Endocrine Society was a...

Endocrinology Advocacy

Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.

Important Advocacy Information From the Endocrine Society

As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.

Both Clinical and Research Advocacy Information

On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.